ASHLEY HINDS: Open Payments
NPI 1154768786 · CROSSVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 23 payments from 8 companies in 2025. Trend: 2023 $422 · 2024 $301 · 2025 $496
Food & beverage: $496
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $83 |
| AstraZeneca Pharmaceuticals LP | 4 | $78 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $77 |
| GENZYME CORPORATION | 4 | $76 |
| GlaxoSmithKline, LLC. | 4 | $67 |
| Regeneron Healthcare Solutions, Inc. | 2 | $58 |
| Boston Scientific Corporation | 1 | $35 |
| BioCryst US Sales Co., LLC | 1 | $22 |
Products named: DUPIXENT, TEZSPIRE, NEFFY, NUCALA, WaveWriter Alpha Prime 16, XOLAIR, ORLADEYO, TRELEGY ELLIPTA.
Industry payments across TN — which companies pay providers there.
